#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alagille syndrome Glycogen storage disease type II Haemophilia A with anti factor VIII Focal segmental glomerulosclerosis Bronchopulmonary dysplasia Endometrial cancer Congenital leptin deficiency Scedosporium infection Pneumonia Metastatic malignant melanoma Type IIa hyperlipidaemia Loss of consciousness Non-Hodgkin's lymphoma unspecified histology indolent Pancreatic carcinoma metastatic Congenital hypotransferrinaemia More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Diagnostics Metachromatic leukodystrophy – Treatment Primary immunodeficiency syndrome – Diagnostics Brain stem glioma – Treatment Cerebral arteriovenous malformation haemorrhagic – Life with Disease CADASIL Thrombotic thrombocytopenic purpura Hyperoxaluria – Trials in Disease Crigler-Najjar syndrome – Diagnostics Synovial sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clomipramine Hydrochloride Bictegravir Alternaria Alternata Extract Valbenazine Ditosylate Temocillin Sodium Cevostamab Glucose, Anhydrous Balstilimab Azd5004 Triptorelin Pamoate Fludeoxyglucose (18F) Perflutren Rbp030.2 Msv-Allo Bi 1819479 Dapansutrile Berzosertib Umeclidinium Ravulizumab Aciclovir More therapies…

    Learn about Your Condition

    Conjunctivitis Pharyngeal cancer stage II Coronary artery dissection Osteosarcoma Liver transplant Portal hypertension Erosive oesophagitis Carpal tunnel syndrome Cancer pain Cardiac failure Renal cell carcinoma Infertility Transplantation complication Schizophrenia Skin bacterial infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Gsk4527226
    Finland France Germany Italy The Netherlands Norway +2

  • Study of Acasunlimab Alone and Combined With Pembrolizumab in Patients With Advanced Skin Melanoma That Returned or Did Not Respond to Prior Treatment

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Acasunlimab
    • Pembrolizumab
    France Germany The Netherlands Spain

  • A study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Overweight
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    Croatia Czechia Hungary Romania Slovakia

  • A Study to Evaluate the Safety of Olipudase Alfa in Children and Adults with Niemann-Pick Disease Who Completed Previous Treatment Studies

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Niemann-Pick disease
    France

  • A study testing ALXN2030 for adults with antibody-mediated rejection after kidney transplantation

    Not recruiting

    2 1
    Investigated Drugs:
    • RNA, (AM-SP-UM-CM-AM-AM-CM-UM-(2′-DEOXY-2′-FLUORO)C-(2′-DEOXY-2′-FLUORO)A-(2′-DEOXY-2′-FLUORO)C-(2′-DEOXY-2′-FLUORO)C-UM-GM-UM-AM-AM-UM-AM-AM-AM-GM-CM-AM-GM-CM-CM-GM-[2′-O-[[2-[2-[[5-[[2-(ACETYLAMINO)-2-DEOXY-BETA-D-GALACTOPYRANOSYL]OXY]-1-OXOPENTYL]AMINO]ETHOXY]ETHOXY]METHYL]]A-[2′-O-[[2-[2-[[5-[[2-(ACETYLAMINO)-2-DEOXY-BETA-D-GALACTOPYRANOSYL]OXY]-1-OXOPENTYL]AMINO]ETHOXY]ETHOXY]METHYL]]A-[2′-O-[[2-[2-[[5-[[2-(ACETYLAMINO)-2-DEOXY-BETA-D-GALACTOPYRANOSYL]OXY]-1-OXOPENTYL]AMINO]ETHOXY]ETHOXY]METHYL]]A-GM-GM-CM-UM-GM-CM), COMPLEX WITH RNA ([4′-DE(HYDROXYMETHYL)-4′-[(HYDROXYMETHOXYPHOSPHINYL)METHOXY]]UM-SP-(2′-DEOXY-2′-FLUORO)U-SP-(2′-DEOXY-2′-FLUORO)U-(2′-DEOXY-2′-FLUORO)A-(2′-DEOXY-2′-FLUORO)U-UM-(2′-DEOXY-2′-FLUORO)A-CM-AM-(2′-DEOXY-2′-FLUORO)G-GM-UM-GM-(2′-DEOXY-2′-FLUORO)A-GM-UM-UM-GM-AM-UM-SP-GM-SP-GM)
    Spain

  • A study testing how well cagrilintide and semaglutide help people with overweight or obesity lose weight

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    France Germany
Previous Page
1 … 944 945 946 947 948 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!